Home›Trial›NCT06026943
🔬NCT06026943NARECRUITING

Alpha Radiation Emitters for the Treatment of Pancreatic Cancer for the Treatment of Locally Advanced Pancreatic Cancer

Study Summary

A unique approach for cancer treatment employing intratumoral diffusing alpha radiation emitter device for advanced pancreatic cancer

Conditions
Pancreatic CancerUnresectable Pancreatic CancerPancreatic Adenocarcinoma
Interventions / Drugs
DaRT seeds insertion
View on ClinicalTrials.gov ↗
Sponsor
DRTS
Alpha Tau Medical Ltd.
Biotech / Pharma
F17/100
Study Details
Enrollment15 participants
Primary Completion—
Lead SponsorAlpha Tau Medical LTD.
Data Retrieved2026-06-17 02:56:49.846040+00:00
Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.